ST-Segment Elevation Acute Myocardial Infarction Complicated by Cardiogenic Shock: Early Predictors of Very Long-Term Mortality.
ST-elevation myocardial infarction
cardiogenic shock
long-term mortality
primary percutaneous coronary intervention
risk score
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 May 2021
21 May 2021
Historique:
received:
02
04
2021
revised:
07
05
2021
accepted:
20
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
Cardiogenic shock (CS) is the leading cause of in-hospital mortality in ST-segment elevation myocardial infarction (STEMI). Only limited data are available on the long-term outcome of STEMI patients with CS undergoing contemporary treatment. We aimed to investigate long-term mortality and its predictors in STEMI patients with CS and to develop a risk score for long-term mortality prediction. We retrospectively included 465 patients with STEMI complicated by CS and treated with primary angioplasty and intra-aortic balloon pump between 2005 and 2018. Long-term mortality, including both in-hospital mortality and all-cause mortality following discharge from the index hospitalization, was the primary endpoint. The long-term mortality (median follow-up 4 (2.0-5.2) years) was 60%, including in-hospital mortality (34%). At multivariate analysis, independent predictors of long-term mortality were age (HR 1.41, each 10-year increase), admission left ventricular ejection fraction (HR 1.51, each 10%-unit decrease) and creatinine (HR 1.28, each mg/dl increase), and acute kidney injury (HR 1.81). When these predictors were pooled together, the area under the curve (AUC) for long-term mortality was 0.80 (95% CI 0.75-0.84). Using the four variables, we developed a risk score with a mean (cross-validation analysis) AUC of 0.79. When the score was applied to in-hospital mortality, its AUC was 0.79, and 0.76 when the score was applied to all-cause mortality following discharge. In STEMI patients with CS, the risk of death is still substantial in the years following the index event. A simple clinical score at the time of the index event accurately predicts long-term mortality risk.
Sections du résumé
BACKGROUND
BACKGROUND
Cardiogenic shock (CS) is the leading cause of in-hospital mortality in ST-segment elevation myocardial infarction (STEMI). Only limited data are available on the long-term outcome of STEMI patients with CS undergoing contemporary treatment. We aimed to investigate long-term mortality and its predictors in STEMI patients with CS and to develop a risk score for long-term mortality prediction.
METHODS AND RESULTS
RESULTS
We retrospectively included 465 patients with STEMI complicated by CS and treated with primary angioplasty and intra-aortic balloon pump between 2005 and 2018. Long-term mortality, including both in-hospital mortality and all-cause mortality following discharge from the index hospitalization, was the primary endpoint. The long-term mortality (median follow-up 4 (2.0-5.2) years) was 60%, including in-hospital mortality (34%). At multivariate analysis, independent predictors of long-term mortality were age (HR 1.41, each 10-year increase), admission left ventricular ejection fraction (HR 1.51, each 10%-unit decrease) and creatinine (HR 1.28, each mg/dl increase), and acute kidney injury (HR 1.81). When these predictors were pooled together, the area under the curve (AUC) for long-term mortality was 0.80 (95% CI 0.75-0.84). Using the four variables, we developed a risk score with a mean (cross-validation analysis) AUC of 0.79. When the score was applied to in-hospital mortality, its AUC was 0.79, and 0.76 when the score was applied to all-cause mortality following discharge.
CONCLUSIONS
CONCLUSIONS
In STEMI patients with CS, the risk of death is still substantial in the years following the index event. A simple clinical score at the time of the index event accurately predicts long-term mortality risk.
Identifiants
pubmed: 34064067
pii: jcm10112237
doi: 10.3390/jcm10112237
pmc: PMC8196779
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Heart. 2005 Mar;91(3):339-44
pubmed: 15710715
Crit Care Med. 2010 Feb;38(2):438-44
pubmed: 19789449
Circulation. 2016 Mar 15;133(11):1135-47
pubmed: 26490017
Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):727-737
pubmed: 28777005
Eur Heart J Acute Cardiovasc Care. 2018 Dec;7(8):743-754
pubmed: 27708109
Circulation. 2018 Nov 11;:
pubmed: 30586721
Ann Intern Med. 2009 Feb 3;150(3):170-7
pubmed: 19189906
JACC Heart Fail. 2015 Mar;3(3):234-42
pubmed: 25742760
Clin Cardiol. 2019 Jan;42(1):111-119
pubmed: 30443916
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Open Heart. 2016 Apr 15;3(1):e000405
pubmed: 27099764
J Clin Med. 2020 Jul 27;9(8):
pubmed: 32727034
N Engl J Med. 1999 Aug 26;341(9):625-34
pubmed: 10460813
JAMA. 2006 Jun 7;295(21):2511-5
pubmed: 16757723
J Am Coll Cardiol. 2017 Apr 18;69(15):1913-1920
pubmed: 28408020
Catheter Cardiovasc Interv. 2011 Oct 1;78(4):505-11
pubmed: 21953748
Cardiovasc Interv Ther. 2018 Oct;33(4):338-344
pubmed: 28918455
Clin Cardiol. 2019 Apr;42(4):484-493
pubmed: 30815887
Eur Heart J. 2012 Oct;33(20):2535-43
pubmed: 22927559
Crit Care Clin. 2014 Jul;30(3):391-412
pubmed: 24996603
Circulation. 2009 Mar 10;119(9):1211-9
pubmed: 19237658
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):270-7
pubmed: 25425723
J Am Heart Assoc. 2016 Jul 06;5(7):
pubmed: 27385429
Am Heart J. 2009 Oct;158(4):680-7
pubmed: 19781431
N Engl J Med. 1999 Apr 15;340(15):1162-8
pubmed: 10202167
BMC Res Notes. 2018 Oct 11;11(1):721
pubmed: 30309379
Clin Cardiol. 2016 Nov;39(11):665-669
pubmed: 27775864
JACC Heart Fail. 2013 Jun;1(3):223-9
pubmed: 24621874
Arch Cardiovasc Dis. 2018 Oct;111(10):555-563
pubmed: 29478810
J Am Heart Assoc. 2014 Jan 13;3(1):e000590
pubmed: 24419737